---
canonical_url: https://www.stockexpertai.com/earnings/eg
last_updated: 2026-05-09T15:26:21.465Z
---

# Everest Re Group, Ltd. (EG) Q4 FY2026 Earnings Preview

> This content was automatically generated with FMP live data + Q1 FY2026 earnings call transcript. Generated: 2026-05-09T15:26:20.979Z. Educational tool, not investment advice.

---

## Quick Summary

| Field | Value | Source |
|---|---|---|
| Price | $351.52 (▼ -0.06%) | fmp:quote |
| Market Cap | $14.0B | fmp:profile |
| 52w range | $302.44 – $368.29 | fmp:quote |
| Earnings | Wed 29 Jul | fmp:earnings-history |
| EPS estimate | $14.58 (-16% YoY) | fmp:earnings-estimate |
| Revenue estimate | $4.1B | fmp:earnings-estimate |
| Beat streak | 1/4 | fmp:earnings-history |
| Rating | A+ (overall 4/5) | fmp:ratings |
| Analyst median target | $365 (+3.8% upside) | fmp:price-target-consensus |
| MoonshotScore | 34/100 | derived |
| Council | 3/6 bullish | derived |
| Munger verdict | Fairly Valued | derived |

## Everest Re Group, Ltd. — Q4 FY2026 Expectations

Q4 consensus: revenue <strong data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvgLabel">$4.1B</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvg" title="FMP est">[FMP est]</sup>, EPS <strong data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">$14.58</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg" title="FMP est">[FMP est]</sup>. 1 consecutive quarters of beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.beatStreakCount" title="FMP earnings">[FMP earnings]</sup>.

## Quick Take

**Score:** A+ · **Stance:** HOLD · **Council:** 3/6 · **Moonshot:** 34

= MoonshotScore <strong>34</strong><sup class="cite" data-source="derived" data-field="moonshot.score" title="9-pillar formula">[9-pillar formula]</sup> + Council <strong>3/6</strong><sup class="cite" data-source="derived" data-field="council.bullishCount" title="6-lens rule">[6-lens rule]</sup>. Form 4: 0 transactions<sup class="cite" data-source="fmp:insider-trading" data-field="insider.txCount" title="FMP Form 4">[FMP Form 4]</sup>.

## Watchlist (6 metrics)

### 1. Mt Logan Aum Growth

Mt. Logan continues to build momentum with assets under management now exceeding $2.6 billion.

> "Mt. Logan continues to build momentum with assets under management now exceeding $2.6 billion."
> — James Williamson, President and CEO, Investor Focus · Q1 FY2026

### 2. Share Repurchase Increase

Everest is increasing its share repurchases, signaling confidence that its share price is undervalued.

> "Effective this quarter, we are raising the quarterly floor on share repurchases from $200 million to $300 million, absent major external dislocation. This reflects our continued conviction that Everest share price today does not accurately reflect either the current value or the true earnings power of the company."
> — James Williamson, President and CEO, Investor Focus · Q1 FY2026

### 3. Global Wholesale Specialty Improvement

Everest's Global Wholesale & Specialty saw a 3.8% improvement in loss experience driven by shifting the portfolio towards short-tail lines and strengthening the quality of the portfolio.

> "And while it's early, we believe mix benefits from our actions to shift the portfolio towards short-tail lines and to strengthen the quality of the portfolio are driving improved loss experience. These actions contributed a 3.8% improvement in our attritional loss ratio to 58.9%, while we continue to set prudent loss picks."
> — Mark Kociancic, Executive Vice President and CFO, Investor Focus · Q1 FY2026

### 4. Treaty Reinsurance Performance

Everest's Treaty Reinsurance segment delivered a strong quarter with a combined ratio of 87.2%.

> "Treaty Reinsurance delivered an excellent quarter, generating $315 million of underwriting income on an 87.2% combined ratio."
> — James Williamson, President and CEO, Investor Focus · Q1 FY2026

### 5. Casualty Premium Reduction

Everest has reduced casualty premium by more than $1.2 billion since January 2024.

> "Since January 2024, we have reduced casualty premium by more than $1.2 billion."
> — James Williamson, President and CEO, Investor Focus · Q1 FY2026

### 6. Property Catastrophe Pricing Softening

Everest notes that property catastrophe pricing continued to soften with rate down 13% on their book globally.

> "Property Catastrophe pricing continued to soften with rate down 13% on our book globally."
> — James Williamson, President and CEO, Investor Focus · Q1 FY2026


## MoonshotScore Pillars

| Pillar | Score | Level | Evidence |
|---|---|---|---|
| Revenue Growth | 0.0 | weak | Q1 vs Q2: growth negative (-7.6%, contraction) |
| Gross Margin | 5.0 | medium | Q1: average margin (45.5%) |
| Operating Leverage | 2.0 | weak | op margin healthy (18.1%) |
| Cash Runway | 3.0 | weak | FCF very strong ($0.6B, 649000000.0× CapEx) |
| R&D Intensity | 3.0 | weak | low R&D investment (0.0%, weak innovation) |
| Price Momentum | 7.0 | strong | RSI 58.4 positive momentum, 50d above |
| News Sentiment | 4.0 | medium | mixed (38% buy) |

**Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula.

## Council (7-Lens)

| Name | Stance | Context |
|---|---|---|
| Ray Dalio | bull | macro · target upside +3.8% |
| Ken Griffin | bull | flow · 50d MA above |
| Jim Simons | neutral | quant · RSI 58 |
| Klarman | neutral | value · target upside +3.8% |
| Buffett | bull | quality · ROE score 4/5 |
| Munger | neutral | valuation · target upside +3.8% |

**Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr.

## Munger Lens

- **Verdict:** Fairly Valued
- **Financial Health:** Strong
- **Margin of Safety:** Weak
- **Interest Coverage:** Adequate
- **ROIC vs WACC:** Healthy

**Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget.

## Technical Levels

- **RSI(14):** 58.4 — yükselişte nötr — overbought sınırının altında, momentum pozitif
- **50d MA:** $335 — hisse %4.9 üstünde — kısa vadeli destek
- **200d MA:** $333 — hisse %5.4 üstünde — uzun vadeli destek
- **Volume (10d):** -22%

## Past Performance (4 Quarters)

| Quarter | EPS Actual | EPS Estimate | Result | Reaction |
|---|---|---|---|---|
| Q2 FY25 | $17.36 | $15.14 | BEAT | +1.0% |
| Q3 FY25 | $7.54 | $14.63 | MISS | -11.4% |
| Q4 FY25 | $13.26 | $13.36 | MISS | -2.3% |
| Q1 FY26 | $16.08 | $13.97 | +15.1% EPS | +3.7% |

Q1 (April 30, 2026): EPS $16.08 vs $13.97 est<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, +15.1% beat. D+1 movement: +3.7%<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP D+1">[FMP D+1]</sup>. Decline despite beat — market reacted to guidance, not numbers.

## 3 Scenarios

### Scenario A · Beat
**Q4 EPS > $14.58 + CapEx discipline**

Threshold: EPS > $14.58<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>.

Target: Break above median target $365<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP target]</sup>; high target $377<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.high">[FMP]</sup> upper bound.

### Scenario B · In-Line
**EPS ≈ $14.58 + CapEx < $0**

Threshold: EPS ≈ $14.58<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>, Q4 CapEx < $0<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel">[FMP]</sup>.

Target: Consolidation in the band between current $352<sup class="cite" data-source="fmp:quote" data-field="quote.price">[FMP]</sup> and median $365<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP]</sup>.

### Scenario C · Miss
**EPS < $14.14 or CapEx ≥ $0**

Threshold: EPS < $14.14<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est×0.97]</sup>.

Target: Current $352 below SMA200 $333<sup class="cite" data-source="fmp:technical" data-field="technical.sma200">[FMP]</sup>, if rejection continues, $283<sup class="cite" data-source="derived" data-field="technical.sma200" data-formula="round(sma200*0.85)">[derived]</sup> support activates.

## Risk Notes

### Primary segment below threshold
Q1: EPS $16.08 vs $13.97 beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, stock +3.7% D+1<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP">[FMP]</sup>.

### Backlog concentration
No RPO/backlog concentration disclosed in Q1 earnings call.

### Insider trading
Form 4 data is marked in the table — this page does not generate assumptions for this stock.

| Executive | Action | Amount | Date |
|---|---|---|---|


**Net:** — (0 transactions · 0 sells · 0 buys) · Q1 FY26

### CapEx shock
Q1 CapEx $0<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel" title="FMP cashflow">[FMP cashflow]</sup>. Q1 op margin 18.1%<sup class="cite" data-source="fmp:income" data-field="income.quarters.0.operatingMargin" title="FMP op margin">[FMP op margin]</sup> — this level in Q4 is sensitive to CapEx revision risk.

## Wall Street Consensus

- **Median target:** $365 (+3.8% upside vs current $352)
- **High / Low:** $377 / $332
- **Buy / Hold / Sell:** 6 / 10 / 0
- **Analyst count:** 4 (last quarter), 29 all-time

## Additional Transcript Insights

### 1. share_repurchase_increase

**Claim:** Everest is increasing its share repurchases, signaling confidence that its share price is undervalued.

**Evidence (transcript):** "Effective this quarter, we are raising the quarterly floor on share repurchases from $200 million to $300 million, absent major external dislocation. This reflects our continued conviction that Everest share price today does not accurately reflect either the current value or the true earnings power of the company."

**Numbers:** $200 million, $300 million

### 2. treaty_reinsurance_performance

**Claim:** Everest's Treaty Reinsurance segment delivered a strong quarter with a combined ratio of 87.2%.

**Evidence (transcript):** "Treaty Reinsurance delivered an excellent quarter, generating $315 million of underwriting income on an 87.2% combined ratio."

**Numbers:** $315 million, 87.2%

### 3. casualty_premium_reduction

**Claim:** Everest has reduced casualty premium by more than $1.2 billion since January 2024.

**Evidence (transcript):** "Since January 2024, we have reduced casualty premium by more than $1.2 billion."

**Numbers:** $1.2 billion, 2024

### 4. property_catastrophe_pricing_softening

**Claim:** Everest notes that property catastrophe pricing continued to soften with rate down 13% on their book globally.

**Evidence (transcript):** "Property Catastrophe pricing continued to soften with rate down 13% on our book globally."

**Numbers:** 13%

### 5. mt_logan_aum_growth

**Claim:** Mt. Logan continues to build momentum with assets under management now exceeding $2.6 billion.

**Evidence (transcript):** "Mt. Logan continues to build momentum with assets under management now exceeding $2.6 billion."

**Numbers:** $2.6 billion

### 6. global_wholesale_specialty_improvement

**Claim:** Everest's Global Wholesale & Specialty saw a 3.8% improvement in loss experience driven by shifting the portfolio towards short-tail lines and strengthening the quality of the portfolio.

**Evidence (transcript):** "And while it's early, we believe mix benefits from our actions to shift the portfolio towards short-tail lines and to strengthen the quality of the portfolio are driving improved loss experience. These actions contributed a 3.8% improvement in our attritional loss ratio to 58.9%, while we continue to set prudent loss picks."

**Numbers:** 3.8%, 58.9%


---

*Data source: FMP (live query, 2026-05-09), Q1 FY2026 earnings call transcript (Translated to EN with Gemini 2.0 Flash). Educational tool, not investment advice.*
